Novel SCN5A p.W697X Nonsense Mutation Segregation in a Family with Brugada Syndrome.
Emanuele MicaglioMichelle M MonaskyNicoletta RestaRosanna BagnuloGiuseppe CiconteLuigi GiannelliEmanuela T LocatiGabriele VicedominiValeria BorrelliAndrea GhiroldiLuigi AnastasiaSara BenedettiChiara Di RestaMaurizio FerrariCarlo PapponePublished in: International journal of molecular sciences (2019)
Brugada syndrome (BrS) is marked by an elevated ST-segment elevation and increased risk of sudden cardiac death. Variants in the SCN5A gene are considered to be molecular confirmation of the syndrome in about one third of cases, while the genetics remain a mystery in about half of the cases, with the remaining cases being attributed to variants in any of a number of genes. Before research models can be developed, it is imperative to understand the genetics in patients. Even data from humans is complicated, since variants in the most common gene in BrS, SCN5A, are associated with a number of pathologies, or could even be considered benign, depending on the variant. Here, we provide crucial human data on a novel NM_198056.2:c.2091G>A (p.Trp697X) point-nonsense heterozygous variant in the SCN5A gene, as well as its segregation with BrS. The results herein suggest a pathogenic effect of this variant. These results could be used as a stepping stone for functional studies to better understand the molecular effects of this variant in BrS.
Keyphrases
- copy number
- genome wide
- genome wide identification
- end stage renal disease
- case report
- electronic health record
- newly diagnosed
- ejection fraction
- dna methylation
- chronic kidney disease
- endothelial cells
- prognostic factors
- peritoneal dialysis
- genome wide analysis
- photodynamic therapy
- machine learning
- induced pluripotent stem cells
- case control
- patient reported